Perdo Cahn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Trials are showing that certain combinations of two antiretrovirals might be as good as three, potentially bringing an end to 25 years of triple therapy dominance.

South africaUnited statesMichelle moorhouseFrancois venterPerdo cahnHuman servicesAfrican health products regulatory authorityDepartment of healthClinical societyHuesped foundationClinicians societyUniversity of the witwatersrandViiv healthcareSouth african governmentInfectious diseasesNucleoside reverse transcriptase inhibitor